SEC Filing Details
Document Details
Form
Filing Date
Aug 7, 2023
Document Date
06/30/23
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.